ACR Home
 



ACR REF/Amgen Pediatric Rheumatology Research Award

We are not accepting applications at this time. For complete information about the award and requirements, please view the application below.

>> Scroll down to view a list of past recipients.

Untitled Document

All applicants and award recipients must abide by REF Awards and Grants Policy at all times.

Application Deadline
The application deadline has passed. Check back in May 2010 for the new application and instructions.

Funding Source
Funding for this award is made possible through an endowment from Amgen, Inc.

For more information about this award, please contact the REF office by e-mail or by phone at (404) 633-3777.

Award Application

 

 
 

If you are unable to view the embedded pdf, verify that you have Adobe Acrobat Reader installed or try viewing the PDF directly.

Your browser does not support embedded PDF files.

2008 Award Recipients

Kaleo C. Ede, MD
The Regents of University of California, Los Angeles

Melissa M. Hazen, MD
Brigham and Women's Hospital

Frank C. Pessler, MD, PhD
Philadelphia VA Medical Center

2007 Award Recipients

Edward M. Behrens, MD
Children's Hospital of Philadelphia
CR3 ligation delivers a "non-danger" signal to dendritic cells to supress stimulatory activity

Neelufar Mozaffarian, MD, PhD
University of Washington Children's Hospital
Altered T lymphocyte responses to maternal cells in pediatric SLE

Eyal Muscal, MD
Baylor College of Medicine
Assessment of cognitive dysfunction in pediatric SLE

2006 Award Recipients

Frank C. Pessler, MD, PhD
Children's Hospital of Philadelphia
Expression of Nuclear Factor of Activated T Cells (NFT) Transcription Factors in the Synovial Subintima Distinguishes RA from OA

Kelly A. Rouster-Stevens, MD, PharmD
Childrens Memorial Hospital
Receptor Activator of Nuclear Factor-kb Ligand/Osteoprotegerin and Bone Mineral Density in Untreated Children with Juvenile Dermatomyositis

Michael Shishov, MD
Cincinnati Children's Medical Center
The MASRI Can Accurately Estimate Adherence with Mediciations in SLE